UnknownPhase 4NCT02234739

Voriconazole for IPA in Chinese Patients With COPD

Studying Aspergillosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Red Cross Hospital, Hangzhou, China
Principal Investigator
Chuang Cai, doctor
Red Cross Hospital, Hangzhou, China
Intervention
Voriconazole(drug)
Enrollment
40 enrolled
Eligibility
30-85 years · All sexes
Timeline
2014 – 2016

Study locations (1)

Collaborators

Sir Run Run Shaw Hospital · Zhejiang Provincial People's Hospital · First People's Hospital of Hangzhou · Second People's Hospital of Hangzhou · The Third Affiliated hospital of Zhejiang Chinese Medical University · Ningbo People's Hospital · Xiaoshan People's Hospital · Xiaoshan Hospital · The First People's Hospital of Huzhou

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02234739 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis →

← Back to all trials